| abstract |
The present invention relates to pyrazoles of formula (I) and their pharmaceutically acceptable salts having activity against CRTH2, where the values of W, L, L, X, L, Y, R and R are as defined in the description and claims, to the use of these compounds as medicines and to pharmaceutical compositions containing said compounds or containing a combination of said compounds with one or more active substances. |